Bridgeway Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-36,800
Closed -$275K 1554
2015
Q2
$275K Sell
36,800
-74,300
-67% -$555K 0.01% 1275
2015
Q1
$664K Sell
111,100
-3,132
-3% -$18.7K 0.01% 974
2014
Q4
$864K Hold
114,232
0.02% 825
2014
Q3
$593K Hold
114,232
0.02% 997
2014
Q2
$492K Buy
114,232
+38,700
+51% +$167K 0.01% 1104
2014
Q1
$309K Buy
75,532
+3,132
+4% +$12.8K 0.01% 1237
2013
Q4
$386K Hold
72,400
0.01% 1155
2013
Q3
$363K Hold
72,400
0.01% 1164
2013
Q2
$323K Buy
+72,400
New +$323K 0.01% 1140